This is my last report as President, unless the scarily efficient Bruce can sneak another one out before May -a task I suspect even he will not be able to achieve. Two years seem to have flown by and in May I will be handing over to Carl Waldmann, in whose capable hands I am sure the Society will continue to flourish.
For a change I am not writing this in a hotel, but on a train. My colleagues back at the coal face will be very grateful when I can spend more time working nearer to home, as will my husband and son. The train is heading to London (I know as much about the GNER timetable as I do Bloomsbury hotels) and I am off to the Critical Care Stakeholder forum meeting. This is a group funded but not owned by the Department of Health which brings together everyone including the Royal Colleges, nurses, professions allied to medicine, networks, SHAs, patients and the private sector to maintain communication and co-ordination around critical care issues. Not always the most entertaining of meetings but one that I feel fulfils a useful function.
There seem to be many Big Issues (capitals intentional) around at the moment, and it seems to me that one of the major roles of the Society is to ensure that the Intensive Care view on these issues is made known. Perhaps the biggest of these currently is 'reconfiguration' of the service; it seems certain there will be major changes in the way secondary care is delivered -but whether this will be driven locally (with all the attendant political lobbying and strife) or with national leadership -is not at all clear to me. The Academy of Medical Colleges were asked to produce a paper for the Department on the effects of reconfiguration on acute services, but unfortunately as we are only a 'specialist society' the ICS will have no direct input to this. We, as the specialty which interacts with all of the acute services, are left out of the direct production of this document, it being assumed that the Royal College of Anaesthetists can speak on our behalf! I have of course pushed as many levers as I can, and fought our corner. Fortunately Pete Nightingale is one of the RCA representatives on this group and he will incorporate our views, but it nevertheless remains annoying to me that the organisation which has a pretty good view on the overall effects of any changes in service delivery is one excluded from this process. If it wasn't for the fact that I suspect the documentation ultimately produced will not be too influential I might get even more upset. This is one more reason why Intensive Care Medicine really does need to achieve firstly Faculty -but ultimately I believe, College status... because we're worth it? Whilst on the subject of the Faculty I have received a few comments, but not as many as anticipated. The inauguration of Faculty status will cause a major change in the way ICM is represented -and potentially a major threat to the future of the Society. Will you for example be happy to pay subscriptions to both the ICS and a Faculty, as well as (for the majority of us who are anaesthetists) the College and the Association? Should the Society change to widen its membership and include more of the professional team in ICM, or should the Intercollegiate Board and the Society merge? If so could we continue to maintain our political functions? These are major dilemmas taxing the Council at present and of importance to all our members. How do you want ICM to be represented in the future?
Many of you will have been deeply (and possibly unhappily) involved in MMC and the round of short listing and imminent interviews. I do have concerns about the effects of the changes to medical education and training on our ability to deliver both the service and over the coming years the number of trained intensivists we will need to take the specialty forward. Last week I attended a meeting of the Workforce Review Team, the body which makes recommendations on the number of training posts required each year to achieve the targets required by the service. This time they had all specialties involved in theatres together. Never one to miss an opportunity, I bribed and brow-beat my colleagues to cover my lists so I could attend and I think it was quite useful. We face a number of problems in ICM; our traditional source of consultants is from anaesthesia, but changes to the anaesthesia curriculum and the reduction in hours associated with the European Working Time Directive will mean that without specific ICM training (which many will I hope strive to obtain) they will not be able to walk straight in to a consultant post on a busy ICU. We may not, however, have enough ICM trained people to fill the gap. I was therefore pleased to hear Stephen Field, the lead Dean for anaesthesia and ICM, say he wanted to train less anaesthetists and more intensivists.
The situation will become much worse over the next few years, as although anaesthesia has had a major expansion in its trainee numbers to facilitate a step change in the number of consultants, the number of trainees appointed annually is planned to drop from 400 to 260 in a couple of years. This change will further compromise the service cover in our ICUs. The trend at the moment (which I think has many good points) is for F2 (and from August -Acute Care Common Stem) trainees to gain ICU experience in the recognition and treatment of acutely ill patients; good for them and for patients, however these people have a large requirement of training and provide little service delivery. We will be further squeezed by the decrease in numbers of anaesthetic trainees and their reduction in time spent in ICM as we move towards competency-based training; 'I have my ICM competencies ticked -I need to go to X rather than ICU'. Solutions to this will obviously differ between units but we do all need to keep our eyes on the ball just in case someone else takes their ball and goes home! Providing accurate information to the workforce review team is obviously very important and this is one of the main reasons for the manpower survey.
There will be a NICE guideline on recognition and treatment of acutely ill patients on wards published in July -David Goldhill is on the working group for this. The NPSA will also produce a report at the same time on these patients, and hopefully (as a result of the efforts of Jane Eddlestone, the DH lead for ICM) these will be joined up, possibly as recommendations for ward care and a reporting mechanism for those still falling through the gaps.
The Mental Capacity Act will be implemented later this year and the Society has successfully bid for funding to run training on its implications, which will be run at the Spring Meeting in Bournemouth. Once again I need to thank David Menon for his persistence and leadership on this difficult issue.
You will have recently received an extra society newsletter about the decision by Eli Lilly to undertake a new trial of Xigris. I received a reply asking about industry funding and links between the Society and drug or equipment companies. I know this is something that many members are concerned about and I thought it might be useful if I included my reply here.
"We (the ICS Executive Committee) agreed to send out this press release because the information would be in the public domain and intensivists may be asked about it by the media, it seemed better to have folks informed rather than not. It would be difficult for Lilly to send this out to such a wide audience because the Society does not share its email list with anyone because of data protection laws." "As a low (very) user of Xigris and someone with a considerable degree of equipoise I am personally pleased that Lilly have agreed to do this. There has been much controversy about Xigris in the medical press and at meetings, and many have called for just such a trial. Given the costs of doing it the only way this could have happened is with Lilly sponsorship. I know nothing about the actual trial except that there will be issues to overcome in conducting a placebo-controlled trial of a drug which is already approved for use." "With relation to Lilly's sponsorship of the Society, we receive between £15-20k per year paid directly to Red Door -our public relations company. There is no interference in the way this is spent and we do not clear press releases from the Society with Lilly. This has been very valuable in getting ICM information into the media and I have no qualms about accepting that funding." "Lilly is an ICS Industry Member and contributes £6-£8k a year, as do all our Company and Corporate Members. The industry sponsorship raised in this way is used to support the ICS research grants and the ICS Director of Research. To raise the same amount of money from our members would mean a subscription increase of more than £50 a head. JICS publication has been sponsored until this year by Lilly, without which we would not have been able to produce such a professional looking product. We are currently looking for another company to provide this sponsorship."
"The Society produced model guidelines for the use of Xigris when it was first launched to give clinicians something to consider using in their units and with their managers. We did not endorse its use, only suggesting the process that should be gone through before the use of a drug which had a randomised, placebo-controlled clinical trial to support its use but was very expensive." "I understand the qualms of members about taking the industry shilling, and am very aware of them. We have never concealed the money industry contributes to the Society and as long as we do not promote their products I am happy to continue to accept it." So that's it folks. It has been an enormous privilege to be President of the Society. I have enjoyed my time hugely and hope I have contributed to the development of the specialty and the furtherance of the Society. I wish Carl all the best in his new role. I need to thank the members of the Secretariat, especially Pauline, and my immensely able and resilient council colleagues for their unstinting efforts to sustain me and the Society over the last 2 years. I also need to thank my new husband for his long-suffering patience -and lastly (but certainly not least) I would like to thank you, the members of the Society, for your support.
Anna Batchelor, President

